Ginobolt-MP1 Tablets

Ginobolt-MP1 is a triple combination therapy designed for effective control of Type 2 Diabetes Mellitus in patients who require enhanced glucose regulation.

• Metformin SR – Improves insulin sensitivity and reduces glucose production in the liver.

• Glimepiride – Stimulates insulin secretion from the pancreas.

• Pioglitazone – Increases peripheral glucose uptake and utilisation.

This formulation offers balanced glycaemic control while minimising daily sugar fluctuations.

Benefits:

• Three-Way Control – Combats insulin resistance, deficiency, and excess glucose production.

• Steady Blood Sugar Levels – SR formulation for prolonged effect.

• Comprehensive Diabetes Care – Suitable for patients needing more than dual therapy.

• Reduced Risk of Long-Term Complications – Supports heart and metabolic health.

Dosage:

One tablet daily with meals, or as directed by a healthcare professional.

Why Cardiever?

• Cardio-Diabetic Care Expertise – Targeted, research-based formulations.

• High-Quality Standards – GMP & ISO certified manufacturing.

• Cost-Effective for Long-Term Use – Affordable without compromising quality.

• Trusted by Doctors – Recommended for advanced diabetes management.